Back to results
US 9,750,730 B2Granted
Apoptosis signal-regulating kinase inhibitor
AssigneeGilead Sciences, Inc.
InventorGregory Notte
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Claims10
A method of treating liver fibrosis comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula (I)
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.